drugset / Trial / NCT00296946
Ipratropium Spray for Drooling Saliva in Parkinson's Disease
Phase 2
Completed
20 enrolled
University Health Network, Toronto
Parkinson's Disease Foundation · collab
RandomizedCrossoverDouble-blindTreatment
Summary
A phase II double blind clinical trial investigating the effects of ipratropium spray versus placebo spray in patients with Parkinson's disease.
Timeline
- Start
- 2004-11
- Primary completion
- —
- Completion
- 2006-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ipratropium | Small molecule | 21 ug | Oral |